Chapter title |
Human Pluripotent Stem Cells (iPSC) Generation, Culture, and Differentiation to Lung Progenitor Cells.
|
---|---|
Chapter number | 11 |
Book title |
Organoids
|
Published in |
Methods in molecular biology, September 2016
|
DOI | 10.1007/7651_2016_11 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7616-4, 978-1-4939-7617-1
|
Authors |
Mahboobe Ghaedi, Laura E. Niklason, Ghaedi, Mahboobe, Niklason, Laura E. |
Abstract |
Induced pluripotent stem (iPS) cells are the product of adult somatic cell reprogramming to an embryonic-like state by inducing a "forced" expression of specific genes. They are similar to natural pluripotent stem cells, such as embryonic stem (ES) cells, in many aspects, such as the expression of certain stem cell genes and potency and differentiability. Human iPS cells are invaluable resource for basic research, cell therapy, drug discovery, and human organ tissue engineering. iPS cells can be derived from the patient to be treated and thus are genetically identical cells that may avoid immune rejection. The following protocols offer a general guideline for the induction of iPSCs from fibroblasts, and for culture and expansion to produce lung precursor cells. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 117 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 19 | 16% |
Student > Master | 11 | 9% |
Student > Ph. D. Student | 10 | 9% |
Researcher | 8 | 7% |
Student > Doctoral Student | 4 | 3% |
Other | 7 | 6% |
Unknown | 58 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 27 | 23% |
Engineering | 6 | 5% |
Chemical Engineering | 4 | 3% |
Agricultural and Biological Sciences | 3 | 3% |
Immunology and Microbiology | 2 | 2% |
Other | 9 | 8% |
Unknown | 66 | 56% |